Article Excerpt: Researchers at Purdue University are developing compounds to provide effective pain relief without the risks associated with opioids. The compounds selectively inhibit adenylyl cyclase 1 (AC1), an enzyme that has previously been validated to target chronic inflammatory pain.
Full Article: https://tinyurl.com/y5lge56m
Article Source: Medical Xpress